One rabbit-gut bacterium, 130 US patents, and a product ladder that climbs from steel-mill smoke to jet fuel, PET plastic, and Gucci perfume. The company is LanzaTech, its cash is nearly gone, and its patent machine just hit record output.
The eVTOL startups raised $15 billion and got the headlines. GE, Rolls-Royce, Pratt, and Safran hold three times as many US electric-propulsion patents, and every one of them keeps a turbine burning.
Histotripsy grants tripled to 12 in 2025, and Michigan plus its $2.25B spinout HistoSonics hold 83% of them. The mechanism is now migrating from liver tumors to the immune system.
Whey and egg white fell years ago. Casein, the self-assembling micelle that makes cheese stretch and melt, is the hard one, and three US startups now hold 19 granted patents on building it without a cow.
Kurzweil said evolution moves toward God’s attributes — complexity, intelligence, creativity, love. Six of the seven are now for sale. The final entry in the scorecard.
Kurzweil’s most mystical chapter predicted a conscious universe. What actually shipped was a patent to make a language model post on your behalf after you die.
Of 28 US patents since 2018 on engineered nitrogen-fixing crop microbes, Pivot Bio holds eight, more than anyone. The trick: deleting the gene that tells the bug to stop.
The self-replicating nanobot Kurzweil feared was never built. But his argument about it — a determined adversary defeats any centralized safeguard — just came true in a biosecurity lab, with a number attached.
The two largest US flow-battery patent estates belong to a Japanese cable maker and Lockheed Martin. The pure-play startup that trails them is nearly out of cash.
In 2024 a machine settled a value of the busy beaver function no human could ever compute by hand — vindicating Kurzweil’s bet on the limits of computation, and the wall that stops both sides.